{"ORPHApacket":[{"ORPHApacketID":"309147","date":"2019-12-06 03:07:51","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"309147","Name":[{"lang":"en","label":"Hyper-beta-alaninemia"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_309147","DisorderType":[{"Name":[{"lang":"en","label":"Disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377788"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Disorder of pyrimidine metabolism"}],"ORPHA":"79193","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_79193"},{"Name":[{"lang":"en","label":"Metabolic diseases with epilepsy"}],"ORPHA":"166481","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_166481"},{"Name":[{"lang":"en","label":"Amino acid or protein metabolism disease with epilepsy"}],"ORPHA":"225689","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_225689"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"A rare, genetic disorder of pyrimidine metabolism characterized by increased serum beta-alanine levels and severe phenotype including hypotonia, malaise, seizures, respiratory distress, lethargy and encephalopahty. Urinary excretion of beta-alanine, beta-amino-isobutyric acid, taurine, and gamma-amino-butyric acid is also elevated. There have been no further descriptions in the literature since 1994."}],"ExternalReferenceList":[{"count":"1","ExternalReference":[{"Source":"OMIM","Reference":"237400","DisorderMappingRelation":[{"id":"21527","Name":[{"lang":"en","label":"E (exact mapping (the terms and the concepts are equivalent))"}]}]}]}],"AverageAgeOfOnsetList":[{"count":"1","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"Neonatal"}]}]}],"SynonymList":[{"count":"1","Synonym":[{"lang":"en","label":"Hyperalaninemia"}]}]}]}